[In the Media] “No Time to Lose in Tackling Dementia: How Should Medicine and Big Pharma Address This Global Challenge?” (Nikkei-Gooday)
date : 11/27/2015
This article featured a conversation between Kiyoshi Kurokawa, Member of the G7 World Dementia Council, and Mr. Joji Nakayama, Representative Director, President & CEO of Daiichi Sankyo Co., Ltd.
For full article:
“No Time to Lose in Tackling Dementia: How Should Medicine and Big Pharma Address This Global Challenge?” (Nikkei-Gooday)
*Available only in Japanese.
Dementia is increasingly becoming an issue around the world. OECD and HGPI co-organized a Private Sector Side Meeting alongside the G7 Global Dementia Legacy Event organized by the Japanese Government in November 2014 in Tokyo.
For more information;
Taking Action on Dementia: Opportunities for Social Investment- A G7 Global Dementia Legacy Event Private Sector Side Meeting
HGPI followed up by submitting a policy recommendation. Later the National Strategy of Dementia was revised and released as what is called the New Orange plan in January 2015 moving dementia policy forward.
For full article:
“No Time to Lose in Tackling Dementia: How Should Medicine and Big Pharma Address This Global Challenge?” (Nikkei-Gooday)
*Available only in Japanese.
Dementia is increasingly becoming an issue around the world. OECD and HGPI co-organized a Private Sector Side Meeting alongside the G7 Global Dementia Legacy Event organized by the Japanese Government in November 2014 in Tokyo.
For more information;
Taking Action on Dementia: Opportunities for Social Investment- A G7 Global Dementia Legacy Event Private Sector Side Meeting
HGPI followed up by submitting a policy recommendation. Later the National Strategy of Dementia was revised and released as what is called the New Orange plan in January 2015 moving dementia policy forward.
Top Research & Recommendations Posts
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines (September 7, 2020)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [New Research Project] Initiative for the Advancement of Dementia Research and Social System Innovation through Global Public Private Partnerships (PPP)